Demonstrates enhanced glycemic and lipid control in rice formulations via hot-melt extrusion, suggesting beneficial dietary effects.
Consumption of white rice, characterized by a high glycemic index (GI) and rapid digestibility, contributes to postprandial glucose spikes and an increased risk of metabolic disorders such as diabetes and obesity. While resistant starch (RS) offers a dietary solution, conventional modification techniques often lack the efficiency to produce high-yield RS. This study utilized hot-melt extrusion (HME) technology to develop functional resistant rice formulations with enhanced physiological properties. Physicochemical characterization using SEM, XRD, FTIR, and TGA revealed that HME processing induced a transition from crystalline to amorphous states, evidenced by the collapse of A-type crystallinity, weakening of hydrogen-bond networks, and partial starch retrogradation. In in vitro functional assays, all HME-processed formulations exhibited superior α-amylase inhibitory activity compared to the control. Notably, formulations F4 and F5 exhibited strong α-amylase inhibition, reaching 62.5% and 68.8%, respectively, even at the lowest tested concentration (1.25 mg/mL). In addition, F5 showed the highest pancreatic lipase inhibition, reaching approximately 80–90%, indicating dual functionality in regulating carbohydrate digestion and lipid hydrolysis. These findings validate HME as an effective, continuous processing strategy for engineering RS-enriched rice matrices. The developed formulations show significant potential as functional food ingredients for obesity management and postprandial glycemic control.
No takes yet. Share an insight, caveat, or question.
Jeon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: